ArticleOncology letters2017
DR2 blocker thioridazine: A promising drug for ovarian cancer therapy.
Min Yong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this papercites it
ArticleOncology letters2017
Min Yong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.